| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | G | 64,869 | $0.00 | $0.00 | View Details Filing |
| Mar 11, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | G | 64,869 | $0.00 | $0.00 | View Details Filing |
| Feb 3, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | M | 8,840 | $0.00 | $0.00 | View Details Filing |
| Feb 3, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | M | 8,840 | $3.76 | $33,238.40 | View Details Filing |
| Jan 28, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | A | 195,952 | $0.00 | $0.00 | View Details Filing |
| Jan 22, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 27,192 | $21.77 | $591,844.76 | View Details Filing |
| Jan 20, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 8,182 | $19.79 | $161,945.51 | View Details Filing |
| Jan 13, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 10,186 | $22.19 | $225,998.82 | View Details Filing |